Thus, according to a joint study by VTsIOM and BIOCAD, trust in Russian pharmaceutical companies as the main argument when choosing drugs has grown to 37%. At the same time, 54% of respondents said that if they had a choice, they would prefer Russian-made medicines, while one in two believes that their quality has improved over the past 25 years.